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Renate Huch and Albert Huch
The technique for measuring 2 transcutaneously (tcPoz) is n°w well
accepted in routine intensive care of the newborn wh i l e Pco2 (tcPco2)
is just being introduced. It is an appropriate time to determine the
Potential va lue of both electrodes and what problems remain to be solved
wi th the tcPeo2 electrode.
tcPco2
Although we reported the first successful attempts to measure Pco2
transcutaneously on adults in 1973 ( 1 ) , the technique has not reached
widespread cl inical use. There are obviously still problems to obtain
a predictable and dependable relat ionship between tcPco2 and Paco2-
Problems are both technical and physiological. Hopefully these can be
overcome in the future.
From the physiological point of view it is important to stress that the
c l i n i c a l l y interesting ränge for Pco2 is much smaller than for Po2· So,
in pr inc ip le , the accuracy and reproducibi l i ty of the technique has to be
better than with transcutaneous Po2- Furthermore, because the Co2 molecule
reacts with water and carbonic acid is formed slowly dissociating into H+
and HCos", the electrode cannot respond äs rapidly äs the Po2 nor can
small or rapid changes in Pco2 be detected.
On the other hand there are some theoretical advantages for transcutaneous
Pco2 compared to Po2- The s k i n Pco2 electrode does not consume Co2 äs
does the 02 electrode so that changes in skin permeability and skin
thickness should not affect correlation between arterial and transcutaneous
Pco2- In i t ia l results are consistent with this expectation. In addit ion,
the essential criteria for the va l id i ty of transcutaneous Po2 -„ su f f i c i en t
blood f low beneath the electrode - seems to be less critical with tcPco2-
Hansen and Tooley (2) reported that even a severe f a l l in mean blood
pressure to äs low äs 20 Torr d id not affect the correlation. The method
also appears to be particularly suited for Physiologie studies of
respiratory control in infants .
tcPo2
The value of continuously monitoring Po2 has been clearly demonstrated by
Yamanouchi in the reduction of RLF (3) . In two nearly identical groups of
immature infants, bir thweights between 650-1500 g and treated between
1974-1977, the incidence of RLF was s ign i f ican t ly lower when these infants
were monitored transcutaneously. This study confirmed those of others that
periods of hypoxaemia or hyperoxaemia can only be prevented when a
continuous oxygen monitoring technique is used in infants with cardio-
respiratory problems.
Prior to the use of continuous oxygen monitoring physicians feit safe with
arterial Po2 values in an acceptable ränge obtained under ideal ,conditions
every 1-2 hours, when monitoring an infant wi th cardiorespiratory
dif f icul t ies . We now know that this confidence in intermittent sampling
was unjus t i f ied (Fig . 1). Arterial Po2 can vary from mlnute to minute to
an extent never believed before even in newborns and premature infants
with normal cardiopulmonary func t ion .
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Fig . l Excerpt from cont inuous registration of transcutaneous Po2 in a
low bir thweight infant (1620 g) demonstrating the great var iab i l i ty
of Po2 and the Information missed when bloodjsamples are taken -
even under ideal conditions - every hours; [62J , [6Ü] mm Hg
Because the tcPo2 ^ s measured cont inuous ly and non- invas ive ly , without
p a i n f u l arterial blood sampl ing which can inf luence the type of breathing,
these variat ipns are real.
The technique of tcPo2 has been useful for routine screening purposes in
the early neonatal period. This enabled us to describe on the basis of
more than 2000 newborns what is physiological and normal in newborn
infants with their special post partum circulatory Status. On the basis
of this experience tcPo2 f luc tua t ions up to 30 mm Hg due to al ternat ing
periods of deeper and shallower breathing have to be considered to be
phys io logica l . Only when the c h i l d is s leeping - and especially when in
so called quiet sleep - does tcPo2 show min imal variations. Because Po2
is so var iable even in healthy infants one has to describe a normal ränge
and not one normal value for a given Si tuat ion.
Fig . 2 shows the histograms from 2000 healthy and quiet newborn infants .
The anterior histogram ( b l a c k ) indicates the m i n i m a l and the posterior
histogram (open) maximal values for tcPo2 at rest dur ing the first day of
l ife.
This f igure demonstrates that there is not one normal va lue for Po2 for
a healthy newborn infant at rest. Al though the possible ränge is large it
is apparent that a m i n i m u m vatue of less than 60 mm Hg at rest occurs in
less than 1% of cases.
Dur ing crying in the first day and week of l i f e 2 u s u a l l y f a l l s ,
sometimes to hypoxaemic levels. A possible explanation is that the intra-
thoracic pressure increase, measured dur ing crying (4 ) , results in R -> L
shunt ing through fetal circulatory passages. Consequently blood samples
taken dur ing crying cannot be used for evaluat ion of cardiorespiratory
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functions. The fact that Ρθ2 decreases during crying provides an
explanation for the great Variation in data that has been reported to







Fig. 2 Histograms of m i n i m a l ( b l a c k ) and maximal (open) tcPo2 values in
quiet phases of healthy newborn infants (n = 2051)
The most widespread use of tcPo2 monitoring has been in the diagnosis,
c l in ica l management and cl inical research of infants and children
suffer ing cardio-pulmonary disease. Systematic continuous studies of the
tcPo2 pattern of these infants have shown that the normal f luctuat ions
described in healthy newborns are dramatically accentuated in the sick
term and preterm infant (reviewed in ( 5 ) ) . tcPo2 has allowed the
Identification of causative factors l inked to the marked Swings in Po2
of these infants.
Continuous tcPo2 has changed and improved our knowledge about what is
physiological and what is normal, and also what is iatrogenic and there-
fore preventable. Expertence with continuous blood gas monitoring did
teil us that the small safe r nge of blood gases in neonates should only
be monitored continuously.
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